Trials / Recruiting
RecruitingNCT07372846
BRI, BMI, and VIDAC Score Relationship in Obese Patients
Evaluation of the Correlation Between Body Roundness Index (BRI), Body Mass Index (BMI), and VIDAC Score in Obese Patients: A Prospective Observational Study
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 90 (estimated)
- Sponsor
- Samsun University · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The VIDIAC score is a measurement system that objectively defines glottic visibility and anatomical complexity in videolaryngoscopy. The literature has shown a relationship between parameters such as BMI, NC, and TMD and difficult airway management in obese patients, but there is no study examining the BRI-VIDIAC relationship.
Detailed description
Obesity is a clinical condition that alters the anatomical airway structure and can increase intubation difficulties. Body Mass Index (BMI) alone is not a sufficient predictor of airway management; it is important in conjunction with measurements such as obesity-related fat distribution, neck circumference, and temporomandibular joint dysfunction (TMD). Body Roundness Index (BRI) is a new anthropometric indicator that reflects body fat distribution more accurately than BMI. The VIDIAC score is a measurement system that objectively defines glottic visibility and anatomical complexity in videolaryngoscopy. The literature has shown a relationship between parameters such as BMI, NC, and TMD and difficult airway management in obese patients, but there is no study examining the BRI-VIDIAC relationship. This study aimed to examine the correlation of BRI and BMI values with the VIDIAC score and to determine whether BRI is a stronger predictor of difficult airway management than BMI.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | VIDEOLARYNGOSCOPE | Videolaryngoscopy imaging in participants with a body mass index greater than 30 kg/m². |
Timeline
- Start date
- 2026-01-02
- Primary completion
- 2026-06-30
- Completion
- 2026-06-30
- First posted
- 2026-01-28
- Last updated
- 2026-01-28
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT07372846. Inclusion in this directory is not an endorsement.